Advertisement

Topics

Novartis To Exit Antibiotic And Antiviral Research

22:43 EDT 12 Jul 2018 | FinanzNachrichten

BASEL (dpa-AFX) - Novartis AG (NVS) said that it would exit antibacterial and antiviral research, the latest in a string of big-pharma departures from the field and the latest move in the company'...

Original Article: Novartis To Exit Antibiotic And Antiviral Research

NEXT ARTICLE

More From BioPortfolio on "Novartis To Exit Antibiotic And Antiviral Research"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...